Boeing $Boeing (BA.US)$ has future contracts, Lockheed Martin has future contracts, so does $Moderna (MRNA.US)$ , $BioNTech (BNTX.US)$ . Now I get the fact that market is not surprised with approvals, in fact it knows it's coming. But future contracts determine valuation. We have 2 billion doses of vaccine contracts contingent upon approvals. Now that contingency is gone, market will inevitably have to value future sales. It's just matter of time.

The biggest mistake I've made while trading was getting too excited with the day trading of $BioNTech (BNTX.US)$ during the earnings report release period.
I bought $BioNTech (BNTX.US)$ very near the historical high and I failed to cut my losses when it fell to the 300s mark. So now I'm just waiting for $BioNTech (BNTX.US)$ to bounce back up to the mid 400s so that I can start afresh with, my limited capital. See below for my position chart

is negative EPS a concern for $Bio-Path Holdings (BPTH.US)$? will it drop further?

$Vivos Therapeutics (VVOS.US)$ The more it falls, the more 🥲

$Novavax (NVAX.US)$ surged with a good news ! cool

$NIO Inc (NIO.US)$ Almost catching up to Li Auto. Well done. lol

$CorMedix (CRMD.US)$ Announcement is probably coming next week.

Asian stocks set to slip after Wall Street retreat
Asian stocks looked set to follow their U.S. peers lower as traders weighed the economic threat of virus restrictions against optimism about the efficacy of vaccines. Treasuries gained.
Futures pointed to modest declines in Japan and Hong Kong, and Australian shares slipped. Futures on the $S&P 500 Index (.SPX.US)$ and $NASDAQ 100 Index (.NDX.US)$ were little-changed after the gauges retreated Thursday, ending a three-day rally amid losses in the consumer discretionary and real estate sectors. Treasuries pared back a rally after a lackluster sale of 30-year bonds. Oil fell toward $70 per barrel and Bitcoin fell. The dollar rose.
U.S. jobless claims decline to lowest level since 1969
Applications for U.S. state unemployment benefits declined last week to the lowest level since 1969, illustrating difficulties adjusting the raw data for seasonal effects.
Initial unemployment claims totaled 184,000 in the week ended Dec. 4, down 43,000 from the prior period, Labor Department data showed Thursday. The median estimate in a Bloomberg survey of economists called for 220,000 applications.
U.S. household net worth posts smallest gain of Covid recovery
Growth in U.S. household net worth cooled in the third quarter as wealth created by rising home values was eroded by a temporary pullback in the stock market.
Household net worth increased by almost $2.4 trillion, or 1.7%, after a $6.14 trillion jump in the second quarter, a Federal Reserve report showed Thursday. While the quarterly advance was the smallest of the pandemic recovery, net worth still climbed to a fresh record of nearly $145 trillion.
Pfizer says booster neutralized Omicron but variant may elude two doses
$Pfizer (PFE.US)$ and $BioNTech (BNTX.US)$ said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.
A third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.
AMC's meme-courting CEO sells $9.65 million more of shares
Adam Aron, chief executive officer of $AMC Entertainment (AMC.US)$, sold another $9.65 million in shares of the meme-driven theater stock, following sales that he had said were prudent for estate planning.
Corporate executives routinely sell stock they get as compensation. But Aron has publicly wooed retail investors and touted AMC's future prospects while selling the stock and benefiting from a mammoth rally in the shares.
AMC shares fell 8.9% to $29.46 in New York. The stock has gained nearly 14-fold this year.
Cathie Wood says Ark 'soul-searching' as once-stellar funds lag
Ark Investment Management is "going through soul-searching" as its growth-focused funds fall out of favor amid expectations of tighter Federal Reserve policy, said founder Cathie Wood.
The $17.8 billion $ARK Innovation ETF (ARKK.US)$ has tumbled more than 20% this year, with several of its top holdings like electric-vehicle giant Tesla Inc. and video-streaming platform Roku Inc. down from their peaks. During the same period, the S&P 500 Index climbed about 24%.
"When we go through a period like this, of course we are going through soul-searching, saying 'are we missing something?'" she said, adding that in response, Ark has doubled down on its research and modeling.
JPMorgan offers hedge funds a way to Dodge meme-stock shocks
$JPMorgan (JPM.US)$ is testing a new research product to guard big-ticket clients from losses linked to the meme stock phenomenon that has captivated Wall Street this year.
Around 30 asset managers and quant fund managers have been trying out the "Through the Retail Lens" data offering since September, the bank said. It's a response to the surprise that hammered investment professionals in January when day traders rushed in to buy stocks, sending the share price of firms including $GameStop (GME.US)$ and AMC Entertainment Holdings Inc. soaring.
Amazon fined $1.3 billion in Italian antitrust case
Italy's antitrust regulator fined $Amazon (AMZN.US)$ $1.3 billion, saying it harmed competitors by favoring third-party sellers that use the company's logistics services, a decision that reflects increased scrutiny of tech giants by antitrust regulators globally.
The regulator said Thursday that Amazon favored sellers in Italy that paid it to use its warehouse and delivery services, including by making them more likely to appear as the default option, or "Buy Box," when consumers click to buy a product.
Source: Bloomberg, WSJ